Harlow
United Kingdom
34
2026-05-14
The entities that hold a legal rights for patent applications filed by inventor Sutton Jonathan Mark:
Jonathan Mark Sutton from Harlow, GB has applied for patents for these inventions. The list has both pending applications and granted patents:
UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF
#2 | 2025-07-31Compounds Useful as RET Inhibitors
#3 | 2025-07-24Heterocyclic Compounds as RET Kinase Inhibitors
#4 | 2024-05-16UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF
#5 | 2024-05-16UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF
#6 | 2024-05-16UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF
#7 | 2024-04-25Compounds Useful as RET Inhibitors
#8 | 2024-04-11Heterocyclic Compounds as RET Kinase Inhibitors
#9 | 2023-10-26Heterocyclic Compounds as RET Kinase Inhibitors
#10 | 2022-11-03Compounds useful as RET inhibitors
#11 | 2022-08-18Urolithin derivatives and methods of use thereof
#12 | 2021-05-27Heterocyclic compounds as RET kinase inhibitors
#13 | 2021-02-18Heterocyclic compounds as RET kinase inhibitors
#14 | 2020-05-21Compounds useful as RET inhibitors
#15 | 2019-08-29Heterocyclic compounds as RET kinase inhibitors
#16 | 2019-04-11Heterocyclic compounds as ret kinase inhibitors
#17 | 2018-01-11Compounds
#18 | 2017-11-30Pyrazolone compounds having human neutrophil elastase inhibitory properties
#19 | 2017-10-31Compounds
#20 | 2017-04-13Pyrimidinone compounds which are HNE inhibitors
#21 | 2016-09-01Pyrimidinone compounds as human neutrophil elastase inhibitors
#22 | 2016-06-16Compounds
#23 | 2015-12-10Compounds
#24 | 2015-06-18Compounds
#25 | 2014-06-26Compounds
#26 | 2014-06-19Pyrimidinone compounds as human neutrophil elastase inhibitors
#27 | 2014-01-16Inhibition of enzymes
#28 | 2013-03-14Compounds
#29 | 2010-10-14EP2 Receptor Agonists
#30 | 2010-05-27EPreceptor agonists
#31 | 2009-12-03EPreceptor agonists
#32 | 2008-05-22EP2 receptor agonists
#33 | 2007-06-14Furan derivatives as EPreceptor antagonists
#34 | 2005-11-17EP2 receptor agonists
141118 ⎘